Dr. Lee received a temporary emergency license to practice in Alabama in April 2020. The license expired in November 2020, but the Alabama State Board of Medical Examiners alleges Dr. Lee continued to write prescriptions for Alabama patients, including for ivermectin, a controversial drug that is sometimes used “off-label” to treat COVID-19 patients, though it’s never been shown to be effective.
Dr. Lee allegedly continued to write prescriptions to patients for months despite being told in January that he was not licensed to practice medicine in Alabama.
The board has issued a cease and desist letter to Dr. Lee ordering him to immediately stop practicing in the state.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
